Having marked its 100th anniversary in 2025, the business has successfully expanded globally, with ten distribution offices in strategic locations. In 2017, Tuttnauer entered a new era of accelerated global growth following its acquisition by Fortissimo Capital, a private equity firm that continues to support the company\u2019s strategic expansion and operational advancement.<\/span> <\/span><\/p>\n\n\n\n Today, Tuttnauer manufactures sterilization devices for the medical, dental, laboratory, and veterinary markets, supplying machines for customers from large hospitals or university research facilities to small clinics and private laboratories. With a newly appointed CEO, Hagay Azani, in place, Tuttnauer\u2019s global growth shows no signs of slowing. We speak with Hagay to explore his vision for advancing the company and delivering a renewed customer experience.<\/span> <\/span><\/p>\n\n\n\n \u201cOur product range is one of our leading points of differentiation, as there are no other competitors in our field that can provide the breadth of autoclave and disinfector product range that we offer,\u201d Hagay opens. \u201cOur portfolio of products includes not only autoclaves but also washer-disinfectors and testing and validation consumables. In addition, we provide comprehensive turnkey solutions, including equipment planning, design, and installation, as well as consultation and feasibility studies for projects of all sizes.<\/span> <\/span><\/p>\n\n\n\n <\/p>\n\n\n <\/p>\n\n\n\n \u201cWe are known for our forward-thinking approach to innovation and continued investment in manufacturing technology and software,\u201d he continues. \u201cIn the last few years, we\u2019ve implemented advanced robotic manufacturing, using sophisticated technology to enhance efficiency and reduce lead times.\u201d<\/span> <\/span><\/p>\n\n\n\n In 2023, Tuttnauer launched T-Connect, a groundbreaking software platform for smart clinics and laboratories seeking to leverage advanced technology to improve workflow efficiency and results. \u201cT-Connect enables paperless documentation for our end users and provides real-time device diagnostics and troubleshooting, empowering users with intelligent data and greater control over their sterilization processes,\u201d Hagay explains. \u201cMany of our customers tell us how much T-Connect has improved their clinics in terms of maintenance and troubleshooting Tuttnauer devices. One of the most difficult challenges a hospital or healthcare facility can face is if a sterilization device malfunctions or needs repair interrupting their workflow process. T-Connect is designed to minimize downtime and ensure a higher standard of reliability.\u201d<\/span> <\/span><\/p>\n\n\n\n With 2025 marking the company\u2019s 100th anniversary, we ask Hagay to share his thoughts on the story behind such success and longevity. \u201cReaching 100 years in business is far more than a symbolic achievement, but rather represents a legacy of expertise, trust, and partnership,\u201d he states. \u201cOur strength comes from doing what we know best. For a century, we have remained dedicated to manufacturing autoclaves that are both premium and reliable; and that focus has never wavered. We\u2019ve simply manufactured and sold sterilization devices for a century. Our production and service teams are among the most experienced in the industry, and many of our employees have been part of the Tuttnauer family for decades. Our teams have a tremendous dedication to this company, and their deep knowledge and commitment are simply invaluable. Such industry expertise has enabled us to build deep, longstanding relationships with many of our distribution partners, and we have grown successfully together over the decades.\u201d<\/span> <\/span><\/p>\n\n\n\n Considering Tuttnauer\u2019s historic success, it\u2019s no surprise that the company is not standing still but instead embarking on a journey of growth via acquisition. \u201cTuttnauer\u2019s growth strategy has been consistent, whether it\u2019s expanding into new markets to strengthen our global footprint or expanding our product portfolio via acquisitions,\u201d Hagay elaborates. \u201cOur acquisition strategy focuses on expanding our capabilities across the full sterilization and infection control workflow. In 2018, we made a strategic investment to partially acquire ATOS, an Italian manufacturing leader in washer-disinfectors, which enabled us to deliver a full sterilization solution of autoclaves washers for the healthcare and laboratory markets.<\/span> <\/span><\/p>\n\n\n\n \u201cThe acquisition of Prestige Medical, a well-established UK distributor, in 2021, enhanced our direct reach across Europe. Also, the partial acquisition of E.C.S. further consolidated our position as a full-cycle sterilization partner, as this product portfolio includes packaging materials and chemical and biological indicators.\u201d<\/span> <\/span><\/p>\n\n\n\n Alongside acquisitions, Tuttnauer is also entering a phase Hagay describes as a \u2018strong focus on manufacturing and supply chain excellence,\u2019 spearheaded by the company\u2019s new production facility in Hungary. \u201cLast year, we opened a large state-of-the-art production facility in Hungary, which is staffed by an experienced team dedicated to producing our market-leading autoclave devices and distributing them worldwide. Opening this site was driven by a clear goal to significantly improve the logistics, availability, and delivery of both spare parts and finished products. This expansion strengthens our global responsiveness and elevates the overall customer experience.\u201d<\/span> <\/span><\/p>\n\n\n\n![\"Hagay](\"https:\/\/manufacturing-today.com\/wp-content\/uploads\/sites\/4\/2026\/02\/Tuttnauer-244-body-image.jpg\")
Success and longevity<\/span><\/h2>\n\n\n\n